Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool February 8, 2005 Stephen D. Simpson	Kyphon Developing a Backbone The small med-tech company posts a rich valuation, but growth is hot, and the market is huge.
The Motley Fool July 6, 2011 Arundhati Parmar	Infuse Furor May Force Medtronic Spine Business Sale. Who Would Buy? Jettisoning the spinal business may not be easy.
American Family Physician August 15, 2002	Vertebroplasty for Spine Fracture Pain How are spinal fractures treated?... What is percutaneous vertebroplasty?... What is the recovery like?... Is the procedure safe?... How do I know if vertebroplasty is right for me?... How successful is vertebroplasty?... etc.
The Motley Fool May 8, 2006 Stephen D. Simpson	A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company.
The Motley Fool November 18, 2008 Brian Orelli	No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy.
The Motley Fool August 4, 2011 Arundhati Parmar	Medtronic Infuse Device Will Be Reviewed by Yale Researchers Medtronic works with Yale on a first-of-its-kind independent review.
Managed Care March 2000 Susan Levine, Lawrence Perin, Diane Hayes, Winifred Hayes	An Evidence-Based Evaluation of Percutaneous Vertebroplasty Costs are relatively low for this minimally invasive procedure, compared with open surgical interventions for vertebral compression fractures, such as internal fixation and spinal fusion.
The Motley Fool July 28, 2010 Brian Orelli	Amplifying the Risk-Reward Ratio Amplify, Medtronic's latest, gets a mixed reaction at FDA advisory panel meeting.
The Motley Fool July 13, 2011 Arundhati Parmar	FDA OKs Study Design on Medtronic Product That Firm Is Bullish On The product is the Simplicity catheter-based system to treat hypertension, or high blood pressure.
The Motley Fool July 27, 2005 Stephen D. Simpson	Back Pain for Shorts? Kyphon continues to defy its skeptics. A developer of minimally invasive technology for the spine, the company saw revenue in the second quarter grow 48% as the U.S. business grew about 41% and overseas sales climbed 99%. Investors, take note.
The Motley Fool August 20, 2008 Brian Orelli	Medtronic Muddles Through The medical device maker manages double-digit growth in a tough market.
The Motley Fool February 20, 2008 Brian Orelli	Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future.
The Motley Fool August 6, 2011 Arundhati Parmar	Medtronic Jobs: Firm Will Double Chinese Workforce in 4 Years The company puts its focus on emerging markets.
The Motley Fool August 22, 2007 Ryan Fuhrmann	Upbeat About Medtronic The future looks bright at medical-device firm Medtronic, and the stock price is reasonable. First quarter sales grew, as overseas revenue improved an impressive 16%.
The Motley Fool March 3, 2011 Bryan Hinmon	Medtronic's Moat Is Strengthening Lessons from an interview with Medtronic CFO Gary Ellis.
American Family Physician August 15, 2002 Predey et al.	Percutaneous Vertebroplasty: New Treatment for Vertebral Compression Fractures Percutaneous vertebroplasty is a newer technique in which acrylic cement is injected through a needle into a collapsed or weakened vertebra to stabilize the fracture. This procedure is effective for treating certain types of painful vertebral compression fractures.
AskMen.com	Fake Study, Real Paycheck Medical device maker Medtronic paid about $850,000 over nearly 10 years to a former Army surgeon accused of forging signatures and falsifying data for a study touting the benefits of one of the company's implants.
The Motley Fool November 15, 2007 Rich Smith	Foolish Forecast: Mulling Medtronic In advance of earnings reports, analysts expect sales from the medical-equipment maker to remain flat and profit to fall slightly.
The Motley Fool March 2, 2011	Fool Q&A: Medtronic CFO Gary Ellis The medical-device maker's chief financial officer talks R&D, "One Medtronic," and growth in emerging markets.
Outside September 2005 Emily Waltz	The Body Shop Athletic injuries of the past could have meant an end to a sports career. These days, however, doctors are using minimally invasive surgical techniques and natural healing methods to increase chances of a full recovery.
HHMI Bulletin May 2011 Dan Ferber	Revealing the Biological Complexity of Bones Bones are the body's framework and support, our strongest tissues. Unlike the scaffold of a building, however, bones are anything but inert. They pulse with life and their maintenance requires a surprisingly delicate balancing act.
The Motley Fool February 9, 2005 Lawrence Meyers	Solid Sales for Florida Rock The company, which provides cement, concrete, and other aggregates for building and construction, continues to benefit from the worldwide cement shortage. The stock has been on a tear lately, leaving investors to wonder how long the good times will last.
The Motley Fool February 24, 2010 Brian Orelli	Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products.
The Motley Fool August 25, 2009 Brian Orelli	Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again.
The Motley Fool January 5, 2007 David Lee Smith	Texas Industries Cements a Quarter The cement and buildings material maker turned in a fine second quarter. Smart investors are urged to keep an eye on this company.
Chemistry World October 15, 2007 Jonathan Edwards	Bones Heal Faster with Nanocrystals A nanocrystalline cement could help bone grafts to heal more quickly, Chinese scientists have claimed.
The Motley Fool August 31, 2011 Harsh Chauhan	Medtronic Looks Set for Takeoff Medtronic shares jump after flat quarterly growth as it looks toward global expansion.
Science News August 28, 2004	Bone Biology A new Web site provides information to physicians and others about bone physiology and osteoporosis.
The Motley Fool May 26, 2005 Stephen D. Simpson	A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges?
The Motley Fool September 22, 2005 Stephen D. Simpson	A Concrete Rose in Texas Having spun off Chaparral Steel to shareholders, Texas Industries is now a cement and aggregate company. While these are good days for the company, it's not going to last forever. Investors, take note.
The Motley Fool November 21, 2007 Rich Smith	Medtronic Motors Ahead Shares of the medical equipment maker soared yesterday and continue to buck the downtrend on Wall Street, in the wake of a fiscal Q2 2008 earnings report that exceeded expectations for both sales and profits.
The Motley Fool November 22, 2011 Brian Orelli	A Little Diversity Goes a Long Way Especially in this economy.
The Motley Fool February 17, 2005 Stephen D. Simpson	Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock?
The Motley Fool January 6, 2005 Stephen D. Simpson	Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past.
The Motley Fool February 9, 2011 Luke Timmerman	Amgen Pushes Ahead With "Son of Dmab" for Treating Bones Is there more to Amgen than "Dmab"?
BusinessWeek December 10, 2009	Policing Corporations Here are some selected settlements of federal cases involving allegations of health-care industry misconduct.
The Motley Fool June 3, 2004 Bill Mann	No Cement? Call Mexico Cement prices are skyrocketing, supplies are dwindling. Good thing we've got those tariffs on Mexico.
Chemistry World February 13, 2013 Michael Parkin	Bone-repairing nanoparticles laced with DNA A bone-repairing nanoparticle paste has been developed that promises faster repair of fractures and breakages. DNA containing two growth-factor genes is encapsulated inside synthetic calcium-phosphate nanoparticles.
The Motley Fool June 29, 2005 Stephen D. Simpson	Medtronic Makes a Fat Deal Medtronic's purchase of the developer of an "obesity pacemaker" could reap rewards in a few years. Investors, take note.
The Motley Fool November 24, 2006 Selena Maranjian	The Best International Stock for 2007: Cemex Investors, this modest cement company based in Mexico is poised to be best international stock for 2007. Here's why.
BusinessWeek June 21, 2004 Catherine Arnst	Guard Your Bones Osteoporosis is one of the biggest health risks facing older women. What can be done to help prevent this disease?
Chemistry World March 18, 2011 Rebecca Brodie	Digging deeper into bone fossils The accuracy of studies on ancient bones of interest to archaeologists and paleontologists can be improved thanks to a new procedure designed by scientists in France.
The Motley Fool January 30, 2008 David Lee Smith	Cemex: Cementing Global Growth Mexico-based cement giant Cemex announces a solid quarter, clearly aided by its last year's purchase of Australia's Rinker Materials.
The Motley Fool May 10, 2011 Arundhati Parmar	Medtronic's MR-Conditional Pacemaker Likely Too Expensive Is Medtronic's pricing choice dragging on this breakthrough product?